WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma.
R. K. Ponce, N. J. Thomas, N. Q. Bui, T. Kondo, R. A. Okimoto
This study identifies WEE1 as a therapeutic target in CIC-DUX4 sarcomas by showing its dependency on WEE1 activity for survival.
bioRxiv · Jun 21, 2021Cancer Biology